A surfactant-stripped cabazitaxel micelle formulation optimized with accelerated storage stability

References

• Alexandridis P, Holzwarth JF, Hatton TA. 1994. Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association. Macromolecules. 27(9):2414–2425.
   Web of Science ®Google Scholar
• Aydin O, Youssef I, Yuksel Durmaz Y, Tiruchinapally G, ElSayed MEH. 2016. Formulation of acid-sensitive micelles for delivery of cabazitaxel into prostate cancer cells. Mol Pharm. 13(4):1413–1429.
   PubMedGoogle Scholar
• Bensaid F, Thillaye Du Boullay O, Amgoune A, Pradel C, Harivardhan Reddy L, Didier E, Sablé S, Louit G, Bazile D, Bourissou D, et al. Y. 2013. Y-shaped mPEG-PLA cabazitaxel conjugates: well-controlled synthesis by organocatalytic approach and self-assembly into interface drug-loaded core-corona nanoparticles. Biomacromolecules. 14(4):1189–1198.
   PubMed Web of Science ®Google Scholar
• Chen W, Guo M, Wang S. 2016. Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system. Drug Dev Ind Pharm. 42(12):1968–1976.
   PubMed Web of Science ®Google Scholar
• de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels J-P, Kocak I, Gravis G, Bodrogi I, Mackenzie MJ, Shen L, et al. 2010. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet. 376(9747):1147–1154.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. 2019. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 144(8):1941–1953.
   PubMed Web of Science ®Google Scholar
• Han X, Chen D, Sun J, Zhou J, Li D, Gong F, Shen Y. 2016. A novel cabazitaxel-loaded polymeric micelle system with superior in vitro stability and long blood circulation time. J Biomater Sci Polym Ed. 27(7):626–642.
   PubMed Web of Science ®Google Scholar
• He B, Tan T, Wang H, Hu H, Wang Z, Wang J, Li J, Sun K, Zhang Z, Li Y, et al. 2018. Rational design of tumor microenvironment-activated micelles for programed targeting of breast cancer metastasis. Adv Funct Mater. 28(8):1705622.
   Web of Science ®Google Scholar
• Hoang B, Ernsting MJ, Tang W-HS, Bteich J, Undzys E, Kiyota T, Li S-D. 2017. Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer. Cancer Lett. 410:169–179.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 65(1–2):271–284.
   PubMed Web of Science ®Google Scholar
• Mahdaviani P, Bahadorikhalili S, Navaei-Nigjeh M, Vafaei SY, Esfandyari-Manesh M, Abdolghaffari AH, Daman Z, Atyabi F, Ghahremani MH, Amini M, et al. 2017. Peptide functionalized poly ethylene glycol-poly caprolactone nanomicelles for specific cabazitaxel delivery to metastatic breast cancer cells. Mater Sci Eng C Mater Biol Appl. 80:301–312.
   PubMed Web of Science ®Google Scholar
• Qu N, Sun Y, Xie J, Teng L-C. 2017. Preparation and evaluation of in vitro self-assembling HSA nanoparticles for cabazitaxel. Anticancer Agents Med Chem. 17(2):294–300.
   PubMed Web of Science ®Google Scholar
• Ren T, Wang Q, Xu Y, Cong L, Gou J, Tao X, Zhang Y, He H, Yin T, Zhang H, et al. 2018. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles. J Control Release. 269:423–438.
   PubMed Web of Science ®Google Scholar
• Sparreboom A, van Zuylen L, Brouwer E, Loos WJ, de Bruijn P, Gelderblom H, et al. 1999. Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications. Cancer Res. 59(7):1454–1457.
   PubMed Web of Science ®Google Scholar
• Sun B, Chitgupi U, Li C, Federizon J, Zhang C, Ruszaj DM, Razi A, Ortega J, Neelamegham S, Zhang Y, et al. 2020. Surfactant-stripped cabazitaxel micelles stabilized by clotrimazole or mifepristone. Adv Therap. 3(3):1900161.
   Google Scholar
• Sun B, Straubinger RM, Lovell JF. 2018. Current taxane formulations and emerging cabazitaxel delivery systems. Nano Res. 11(10):5193–5218.
   Web of Science ®Google Scholar
• Xue P, Liu D, Wang J, Zhang N, Zhou J, Li L, Guo W, Sun M, Han X, Wang Y, et al. 2016. Redox-sensitive citronellol-cabazitaxel conjugate: maintained in vitro cytotoxicity and self-assembled as multifunctional nanomedicine. Bioconjug Chem. 27(5):1360–1372.
   PubMed Web of Science ®Google Scholar
• Zeng YY, Zeng YJ, Zhang NN, Li CX, Xie T, Zeng ZW. 2019. The preparation, determination of a flexible complex liposome co-loaded with cabazitaxel and β-elemene, and animal pharmacodynamics on paclitaxel-resistant lung adenocarcinoma. Molecules. 24(9):1697.
   Web of Science ®Google Scholar
• Zhang Y, Song W, Geng J, Chitgupi U, Unsal H, Federizon J, Rzayev J, Sukumaran DK, Alexandridis P, Lovell JF, et al. 2016. Therapeutic surfactant-stripped frozen micelles. Nat Commun. 7:11649.
   PubMed Web of Science ®Google Scholar
• Zhong T, He B, Cao H-Q, Tan T, Hu H-Y, Li Y-P, Zhang Z-W. 2017. Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles. Acta Pharmacol Sin. 38(6):924–930.
   PubMed Web of Science ®Google Scholar
• Zhou G, Jin X, Zhu P, Yao JU, Zhang Y, Teng L, Lee RJ, Zhang X, Hong W. 2016. Human serum albumin nanoparticles as a novel delivery system for cabazitaxel. Anticancer Res. 36(4):1649–1656.
   PubMed Web of Science ®Google Scholar
• Zhuang B, Du L, Xu H, Xu X, Wang C, Fan Y, Cong M, Yin J, Li H, Guan H, et al. 2016. Self-assembled micelle loading cabazitaxel for therapy of lung cancer. Int J Pharm. 499(1–2):146–155.
   PubMedGoogle Scholar